EC Number |
Inhibitors |
Structure |
---|
2.7.4.9 | (+/-)(Z)-5-acetamido-1-(4-(thymin-1-yl)but-2-enyl)-5,6-dihydro-1H-imidazo[4,5,1-ij]quinolin-2(4H)-one |
- |
|
2.7.4.9 | (+/-)(Z)-5-amino-1-(4-(thymin-1-yl)but-2-enyl)-5,6-dihydro-1H-imidazo[4,5,1-ij]quinolin-2(4H)-one |
- |
|
2.7.4.9 | (3-chlorophenoxy)-4-((R)-1-((S)-3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)piperidin-1-yl)propyl)benzoic acid |
- |
|
2.7.4.9 | (3-chlorophenoxy)-4-((S)-1-((S)-3-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)piperidin-1-yl)propyl)benzoic acid |
- |
|
2.7.4.9 | (3E)-4-[4-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]but-3-enoic acid |
comparison with inhibition of Mycobacterium tuberculosis enzyme |
|
2.7.4.9 | (3E)-4-[4-[(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl]phenyl]but-3-enoic acid |
comparison with inhibition of human enzyme |
|
2.7.4.9 | (4E)-1-(4-hydroxy-3-methoxyphenyl)dec-4-en-3-one |
i.e. [6]-shogaol, isolated from Zingiber officinale |
|
2.7.4.9 | (E)-5-(2-bromovinyl)-deoxyuridine |
- |
|
2.7.4.9 | (NH4)2SO4 |
0.35 M, 50% inhibition |
|
2.7.4.9 | (R)-1-(1-(3-(3,4-dichlorophenoxy)benzyl)piperidin-3-yl)-5-methylpyrimidine-2,4(1H,3H)-dione |
- |
|